Agios to Present at the Virtual Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020

Rhea-AI Summary

Agios Pharmaceuticals (NASDAQ:AGIO) announced its participation in the virtual Canaccord 40th Annual Growth Conference on August 13, 2020, at 1:00 p.m. ET. The presentation will be available via live webcast under the 'Events & Presentations' section on Agios' website. A replay will be accessible for at least two weeks post-event. Agios focuses on developing innovative medicines for cancer and rare genetic diseases, boasting both approved therapies and a robust pipeline of investigational drugs. For more details, visit www.agios.com.

CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to present at the virtual Canaccord 40^th Annual Growth Conference on Thursday, August 13, 2020 at 1:00 p.m. ET.

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. A replay of the webcast will be archived on the Agios website for at least two weeks following the presentation.

About Agios
Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development. For more information, please visit the company's website at www.agios.com.

Contacts

Investors:
Holly Manning, 617-844-6630
Director, Investor Relations
Holly.Manning@agios.com

Media:
Jessica Rennekamp, 857-209-3286
Associate Director, Corporate Communications
Jessica.Rennekamp@agios.com

FAQ

When is Agios Pharmaceuticals presenting at the Canaccord 40th Annual Growth Conference?

Agios Pharmaceuticals will present on August 13, 2020, at 1:00 p.m. ET.

How can I watch the Agios Pharmaceuticals conference presentation?

The presentation can be accessed via a live webcast in the 'Events & Presentations' section on Agios' website.

Will the Agios Pharmaceuticals presentation be available after the event?

Yes, a replay of the presentation will be archived on the Agios website for at least two weeks.

What does Agios Pharmaceuticals focus on?

Agios develops investigational medicines for cancer and rare genetic diseases, emphasizing cellular metabolism.

What are some products of Agios Pharmaceuticals?

Agios has two approved oncology precision medicines and multiple investigational therapies in various development stages.